Disease/Infection News

RSS

Montana State researcher helps develop a better understanding of COVID-19 spread

How many people in the U.S. have had COVID-19? Using a database of information collected after the 2009 H1N1 outbreak, a Montana State University researcher is helping develop a better understanding of the spread of the novel coronavirus.

26 Jun 2020

George Mason researcher developing solution to help confine epidemics

Sai Manoj Pudukotai Dinakarrao, Assistant Professor, Electrical and Computer Engineering, is developing a scalable and connectivity-aware solution that he hopes will help confine the COVID-19 pandemic and future epidemics.

26 Jun 2020

UVA Health receives FCC grant to expand use of COVID-19 telehealth care

The Federal Communications Commission awarded UVA Health $767,139 this week to expand UVA's use of telehealth for patient care during the COVID-19 pandemic.

26 Jun 2020

Pediatric patients more resilient against COVID-19 compared to adults

The majority of children with COVID-19 in 26 countries fared well clinically compared to adults during the first four months of the pandemic, a newly released study shows.

26 Jun 2020

New Ebola strain may emerge in the Democratic Republic of Congo, say scientists

Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.

26 Jun 2020

Sweeps of homeless camps run counter to COVID guidance and pile on health risks

Melody Lewis lives like a nomad in the heart of downtown. Poking her head out of her green tent on a recent June day, the 57-year-old pointed a few blocks away to the place where city crews picked up her tent from a sidewalk median earlier this spring and replaced it with landscaping rocks, fencing and signs warning trespassers to keep out.

26 Jun 2020

Timing of antibody testing is critical for accurate COVID-19 detection

Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.

26 Jun 2020

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

As experts in hematology HORIBA UK Ltd, Medical announces that the Company has published a white paper entitled, ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients’.

From HORIBA Medical 26 Jun 2020

BATM provides business and trading update

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following business and trading update.

26 Jun 2020

Understanding dexamethasone’s role in treating COVID-19

While the steroid medicine dexamethasone may help people with serious COVID-19 illness, it should only be given to people very ill in hospital and shouldn’t be taken by anyone to try to prevent COVID-19 or for less severe cases.

26 Jun 2020

GlobalData: Uncertainty during COVID-19 increases demand for immunity-boosting products

Ongoing research around protective immunity against COVID-19 has not yet helped to define ways of how the public can protect themselves from the illness, minimize the symptoms, and avoid re-infection.

26 Jun 2020

Seniors in low-income housing live in fear of COVID infection

Davetta Brooks, 75, who has heart failure, a fractured hip and macular degeneration, is afraid. Conditions in her low-income senior building on Chicago's Near West Side — the Congressman George W. Collins Apartments — are "deplorable," she said.

26 Jun 2020

Ecolab increases production capacity to meet exponential demand for hand sanitizers

In response to the pandemic, Ecolab, the global leader in water, food safety and infection prevention solutions and services, has increased its production capacity seven fold in Europe to provide customers with critical hand sanitizer and surface disinfectant solutions to help prevent the spread of SARS-CoV-2, the virus that causes COVID-19.

26 Jun 2020

GlobalData: NEJM study further confirms link between heart disease and death from COVID-19

Following the recent publication of a study in the New England Journal of Medicine that further confirms the elevated risk of in-hospital death amongst COVID-19 patients with concomitant cardiovascular disease;

26 Jun 2020

Fatalities are very rare in children with COVID-19

Children with COVID-19 generally experience a mild disease and fatalities are very rare, according to a study of 582 patients from across Europe published today in The Lancet Child & Adolescent Health journal.

26 Jun 2020

Study shows COVID-19 infection is a risk factor for acute strokes

COVID-19 infection is significantly associated with strokes, and patients with COVID-19 should undergo more aggressive monitoring for stroke.

26 Jun 2020

IQWiG supports initial assessment of coronavirus diagnostics

As a founding member, the Institute for Quality and Efficiency in Health Care (IQWiG) has been involved in EUnetHTA, a European network for Health Technology Assessment (HTA), since 2006.

26 Jun 2020

ASPS conducts survey to gauge public's mindset on preferred treatments

As the COVID-19 pandemic has changed how plastic surgeons will care for patients and how they operate their practices, the American Society of Plastic Surgeons (ASPS) recently conducted a member survey to understand what procedures were top of mind among patients to gauge whether the public's mindset on preferred treatments has shifted.

26 Jun 2020

Antibody tests may give false hope of immunity, health experts warn

Amid the coronavirus pandemic, health experts warn against the use of antibody tests to determine if a person has immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An antibody test determines if a person developed antibodies against the infection due to past exposure.

26 Jun 2020

China to initiate phase 3 SARS-CoV-2 vaccine trial in UAE

Now, China is ready to run its large-scale phase III clinical trial of its novel coronavirus candidate in the United Arab Emirates (UAE). Over a dozen experimental vaccines are being trialed across the globe, but China’s vaccine is the first one to proceed to phase III human trials.

26 Jun 2020